{Reference Type}: Case Reports
{Title}: Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report.
{Author}: Ranno S;Fontanel L;Ruggiero E;Nucci P;Radice P;Donati S;
{Journal}: Ital J Pediatr
{Volume}: 49
{Issue}: 1
{Year}: Jan 2023 3
{Factor}: 3.288
{DOI}: 10.1186/s13052-022-01386-4
{Abstract}: <B>BACKGROUND: </B>Corticosteroids are widely used in medicine. Few cases of central serous chorioretinopathy (CSC) have been reported following topical corticosteroid administration. We describe the first case of pediatric CSC related to topical corticosteroid administration.<BR><B>METHODS: </B>A 14-year-old boy presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in the right eye after starting treatment for atopic dermatitis with Betamethasone Valerate 0.1% topical ointment. His condition resolved 2 weeks after discontinuing the steroid and administering Bromfenac 0.9 mg/ml eyedrops.<BR><B>CONCLUSIONS: </B>Although the pathogenesis of CSC is poorly understood, ophthalmologists should be informed about the potential link between CSC and topical corticosteroid treatment, and they should be aware that CSC might, albeit infrequently, affect children.